asco 2022: destiny-breast04, paloma-2, reecur
Published 2 years ago • 619 plays • Length 4:18Download video MP4
Download video MP3
Similar videos
-
3:31
asco daily news 2022 plenary update - lba3: destiny-breast04
-
2:01
destiny-breast04: practice-changing results for her2-low breast cancer
-
0:56
destiny-breast04: t-dxd for patients with her2-low mbc
-
1:08
destiny-breast04: a ground-breaking trial in her2-low breast cancer
-
7:39
asco 2022: trastuzumab deruxtecan vs. treatment of physician's choice in her2-low unresectable a...
-
0:54
breast cancer highlights at asco 2022
-
1:10
destiny-04: her2 1 /fish- metastatic breast cancer tdxd treatment | jane meisel, md | asco22 updates
-
8:47
chemotherapy and targeted therapy for her2-negative metastatic breast cancer that is either endoc...
-
7:36
asco 2022: metastatic breast cancer drug therapy recap
-
1:02
key takeaways from asco 2022
-
5:11
destiny-breast04: t-dxd provides significant improvement in os pfs in her2-low mbc
-
6:38
palbociclib in metastatic breast cancer. discussion of the paloma-2 results.
-
0:51
what to look forward to in breast cancer at asco 2022?
-
24:56
her2 testing in breast cancer: asco-cap guideline update
-
0:59
asco 2012 - t-dm1 for her 2 positive advanced breast cancer
-
4:39
asco: early studies show promise in treating metastatic breast cancer
-
2:12
trastuzumab deruxtecan in her2-low advanced breast cancer | nejm
-
4:19
asco: new treatment (t-dm1) for her2-positive advanced breast cancer?
-
2:05
latest news in her2-low breast cancer